Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges

Polygonum multiflorum Thunb. (PM), called Heshouwu in China, is a popular Chinese medicine in clinical practice. Several clinical studies have been conducted to evaluate the traditional therapeutic claims and to study the potential therapeutic activity of PM in dyslipidemia and neurodegenerative dis...

Full description

Bibliographic Details
Main Authors: Yi Liu, Wenping Wang, Mingyi Sun, Baorui Ma, Linnuo Pang, Yuanyuan Du, Xiaoxv Dong, Xingbin Yin, Jian Ni
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01467/full
_version_ 1818194448938434560
author Yi Liu
Wenping Wang
Mingyi Sun
Baorui Ma
Linnuo Pang
Yuanyuan Du
Xiaoxv Dong
Xingbin Yin
Jian Ni
author_facet Yi Liu
Wenping Wang
Mingyi Sun
Baorui Ma
Linnuo Pang
Yuanyuan Du
Xiaoxv Dong
Xingbin Yin
Jian Ni
author_sort Yi Liu
collection DOAJ
description Polygonum multiflorum Thunb. (PM), called Heshouwu in China, is a popular Chinese medicine in clinical practice. Several clinical studies have been conducted to evaluate the traditional therapeutic claims and to study the potential therapeutic activity of PM in dyslipidemia and neurodegenerative diseases, highlighting available clinical evidence. In recent years, reports on clinical adverse reactions of Raw Radix P. multiflorum (RPM) and P. multiflorum Praeparata (PMP) have been on the increase, especially with respect to liver injury. Most liver injury cases had been assessed for causality using RUCAM (Roussel Uclaf Causality Assessment Method) in this paper. However, the components of PM responsible for the reported hepatotoxic effects have not yet been identified. Moreover, many of the reports are contradictory, while studies on the mechanism involved in PM-induced liver damage are not comprehensive. This study was aimed at reviewing the status of research on liver injury due to PM, including clinical characteristics, risk factors, material basis research and mechanism of action, with a view to understanding PM-induced hepatotoxicity, and taking reasonable and effective measures to prevent it. In short, quality control is still one of the major safety problems in TCM drug safety concerns. The model of safety monitoring and risk management of PM drugs is not yet developed. Indeed, the characteristics and risk factors associated with PM require both proper understanding and control of the risk by strengthening standardization of clinical applications, basic science research, quality control in manufacturing, active monitoring methodology and enhancement of international communication and cooperation. Measures should also be encouraged and implemented to promote healthy development of the TCM industry.
first_indexed 2024-12-12T01:02:28Z
format Article
id doaj.art-2adbc8f37a4a4cab88a1680bb2905d22
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-12T01:02:28Z
publishDate 2019-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-2adbc8f37a4a4cab88a1680bb2905d222022-12-22T00:43:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-12-011010.3389/fphar.2019.01467484074Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current ChallengesYi Liu0Wenping Wang1Mingyi Sun2Baorui Ma3Linnuo Pang4Yuanyuan Du5Xiaoxv Dong6Xingbin Yin7Jian Ni8School of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaSchool of Chinese Materia Medica, Beijing University of Traditional Chinese Medicine, Beijing, ChinaResearch Institute of Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing, ChinaPolygonum multiflorum Thunb. (PM), called Heshouwu in China, is a popular Chinese medicine in clinical practice. Several clinical studies have been conducted to evaluate the traditional therapeutic claims and to study the potential therapeutic activity of PM in dyslipidemia and neurodegenerative diseases, highlighting available clinical evidence. In recent years, reports on clinical adverse reactions of Raw Radix P. multiflorum (RPM) and P. multiflorum Praeparata (PMP) have been on the increase, especially with respect to liver injury. Most liver injury cases had been assessed for causality using RUCAM (Roussel Uclaf Causality Assessment Method) in this paper. However, the components of PM responsible for the reported hepatotoxic effects have not yet been identified. Moreover, many of the reports are contradictory, while studies on the mechanism involved in PM-induced liver damage are not comprehensive. This study was aimed at reviewing the status of research on liver injury due to PM, including clinical characteristics, risk factors, material basis research and mechanism of action, with a view to understanding PM-induced hepatotoxicity, and taking reasonable and effective measures to prevent it. In short, quality control is still one of the major safety problems in TCM drug safety concerns. The model of safety monitoring and risk management of PM drugs is not yet developed. Indeed, the characteristics and risk factors associated with PM require both proper understanding and control of the risk by strengthening standardization of clinical applications, basic science research, quality control in manufacturing, active monitoring methodology and enhancement of international communication and cooperation. Measures should also be encouraged and implemented to promote healthy development of the TCM industry.https://www.frontiersin.org/article/10.3389/fphar.2019.01467/fullPolygonum multiflorum Thunb.liver injurysafety evaluationclinical characteristicsmaterial basisaction mechanism
spellingShingle Yi Liu
Wenping Wang
Mingyi Sun
Baorui Ma
Linnuo Pang
Yuanyuan Du
Xiaoxv Dong
Xingbin Yin
Jian Ni
Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges
Frontiers in Pharmacology
Polygonum multiflorum Thunb.
liver injury
safety evaluation
clinical characteristics
material basis
action mechanism
title Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges
title_full Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges
title_fullStr Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges
title_full_unstemmed Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges
title_short Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges
title_sort polygonum multiflorum induced liver injury clinical characteristics risk factors material basis action mechanism and current challenges
topic Polygonum multiflorum Thunb.
liver injury
safety evaluation
clinical characteristics
material basis
action mechanism
url https://www.frontiersin.org/article/10.3389/fphar.2019.01467/full
work_keys_str_mv AT yiliu polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT wenpingwang polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT mingyisun polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT baoruima polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT linnuopang polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT yuanyuandu polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT xiaoxvdong polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT xingbinyin polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges
AT jianni polygonummultifloruminducedliverinjuryclinicalcharacteristicsriskfactorsmaterialbasisactionmechanismandcurrentchallenges